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increase in protein expression level. This suggested that UV
irradiation promotes both activation and expression levels of the
Rfp-Ret kinase. Rfp-Ret kinase is constitutively active due to
its oncogenic mutation (Takahashi et al, 1985). Thus, UV-
mediated superactivation of the mutant Ret kinase, which was
originally demonstrated in vitro (Kato et al, 2000), probably
occurred also in vivo. The signal triggered through super-
activation of Rfp-Ret kinase by UV might have promoted the
production of Rfp-Ret together with ERK and c-Jun, although
alternative mechanisms remain to be excluded. Whatever the
underlying mechanism is, our data suggest that UV-induced full
activation of a single oncogene and its product is included in
the mechanism of malignant melanocytic tumor promotion, in
addition to previously reported stepwise recruitment of multiple
oncogene activations (Ziegler et al, 1994) and defects in the
host defense mechanism (Kripke, 1979). This may stimulate
new experiments for fully understanding the general mechanism
of malignant tumor promotion following initiation.
We thank K. Ban, Y. Umeda, Y. Kato, H. Saeki, and K. Uchiyama for their
technical assistance. This study was supported in part by Grants-in-Aid for COE
Research, for Scienti®c Research on Priority Areas and for Scienti®c Research (C)
from the Ministry of Education Science, Sports and Culture of Japan, the Fund for
Comprehensive Research on Aging and Health from the Ministry of Health and
Welfare, the Cosmetology Research Foundation, Lydia O'Leary Memorial
Foundation, and the Aichi Cancer Research Foundation.
Masashi Kato, Wei Liu, Anwarul A. Akhand, Khaled Hossain,
Kozue Takeda, Masahide Takahashi*, Izumi Nakashima
Departments of Immunology and *Pathology,
Nagoya University School of Medicine,
Showa-ku, Nagoya, Aichi, Japan
REFERENCES
Iwamoto T, Takahashi M, Ito M, et al: Aberrant melanogenesis and melanocytic
tumor development in transgenic mice that carry a metallothionein/ret fusion
gene. EMBO J 10: 3167±3175, 1991
Kato M, Takahashi M, Akhand AA, et al: Transgenic mouse model for skin malignant
melanoma. Oncogene 17: 1885±1888, 1998
Kato M, Liu W, Akyhand AA, et al: Linkage between melanocytic tumor
development and early burst of Ret protein expression for tolerance
induction in metallothionein-I/ret transgenic mouse lines. Oncogene 18: 837±
842, 1999
Kato M, Iwashita T, Takeda K, et al: Ultraviolet light induces redox reaction-
mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.
Mol Biol Cell 11: 93±101, 2000
Kripke ML: speculations on the role of ultraviolet radiation in the development of
malignant melanoma. J Natl Cancer I 63: 541±548, 1979
Takahashi M, Ritz J, Cooper GM: Activation of a novel human transforming gene,
ret, by DNA rearrangement. Cell 42: 581±588, 1985
Ziegler A, Jonason AS, Leffell DJ, et al: Sunburn and p53 in the onset of skin cancer.
Nature 372: 773±776, 1994
A Prospective Study of Incident Nonmelanoma Skin Cancer
in Heart Transplant Recipients
To the Editor:
The high incidence of nonmelanoma skin cancer (NMSC) in
transplant recipients is mainly due to immunosuppressive treatment
(EspanÄa et al, 1995; Bouwes-Bavinck et al, 1996; Jensen et al, 1999;
Ong et al, 1999). An increased exposure to ultraviolet radiation may
lead to an even higher risk (Kelly et al, 1987; Gallagher et al, 1995;
Krutman, 1997). We describe the incidence of NMSC in heart
transplant recipients (HTR) from a single Spanish center and assess
their main risk factors.
Out of 150 HTR between January 1984 and December 1997,
those who had a follow-up time superior to 6 mo after
transplantion (n = 124) were included in our assessment. Their
follow-up times were: >3 y, 80 patients; >5 y, 52 patients; >7 y, 27
patients; >9 y, 15 patients.
These selection criteria ensured that this series was comparable
with other reports (Couetil et al, 1990), including a previous shorter
Figure 2. Repeated UV irradiation induced the malignant tumor
promotion. Tissues of tumors from RFP-RET-transgenic mice of line 192
that had received sham irradiation (A) or repeated UV irradiation (B) were
stained with haematoxylin and eosin. (A) The tumor was composed of
round cells with round nuclei and low mitotic activity. (B) The tumor was
composed of atypical cells with various-sized nuclei and high mitotic
activity. Histologic properties of these benign and malignant tumors were
basically the same as those of the tumors we reported previously, which
spontaneously developed in the RFP-RET-transgenic mice of lines 304
Kato et al, 1998). Representative pictures only are shown. Scale bar: 15 mm.
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assessment by our group (EspanÄa et al, 1995). The median follow-
up time was 69 mo (range: 6±161 mo). Eighty-eight per cent of the
patients were male and their mean age was 49 y. All patients were
living in Spain (latitude 40°-45° North).
All patients were counselled to avoid sun exposure and to use
sunscreens. Immunosuppressive protocols received by these
patients are fairly homogenous (EspanÄa et al, 1995). All patients
were carefully examined by the same dermatologist (AE) every
6 mo. We assigned a score (hereafter referred to as total sun
burden (TSB)) to each patient according to a questionnaire that
they completed. To build this score we summed the points
during four periods of lifetime until receiving the transplant
(< 20 y, 20±40 y, 41±60 y, >60 y) related to their exposure to
three factors: usual residence (nonsunny = 0 points, sunny = 1
point); occupational sun exposure (never = 0, < 20 h per
wk = 1, > 20 h per wk = 3), sun exposure during vacations
(nothing = 0, < 14 d per y = 1; > 14 d per y = 2). This system
could theoretically lead to values ranging 0±24, but we obtained
actual scores ranging 1±20. We categorized the patients in three
roughly similar groups of TSB. All patients in our series
belonged to categories I±IV of skin-type (ST) (Fitzpatrick,
1988). We merged ST I±II into a single category; and ST III±
IV into another category. We calculated with the Kaplan-Meier
method (using the ®rst episode as event) the cumulative
incidence of NMSC for each group of patients according to
their TSB exposure and to their ST. We compared incidence
rates with the log-rank test. We performed sensitivity analyzes
considering deaths as censor or as events for patients not
Table I. Relative risk of NMSC in HTR according to several risk factorsa
Relative risk of SCC
(95% con®dence intervals)
Relative risk of BCC
(95% con®dence intervals)
Relative risk of any skin cancer
(95% con®dence intervals)
Multivariate Multivariate Multivariate
Exposure Crude adjustedb Crude adjustedb Crude adjustedb
Total sun burden score
Low (<6) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Moderate (6±10) 4.46
(0.576±34.57)
6.03
(0.634±57.34)
2.53
(0.305±21.02)
2.93
(0.279±30.65)
3.29
(0.752±14.41)
4.95
(0.916±26.77)
High (>10) 19.39
(2.52±149.38)***
19.86
(2.18±180.61)***
8.90
(1.11±71.26)*
6.08
(0.6021±61.45)
12.24
(2.79±53.64)***
13.71
(2.60±72.40)***
Skin types
Burns in sun (I/II) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Tans in sun (III/IV) 0.131
(0.055±0.314)***
0.128
(0.051±0.317)***
0.270
(0.098±0.772)*
0.381
(0.120±1.21)
0.183
(0.090±0.373)***
0.169
(0.078±0.365)***
Gender
Male 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Female 0.547
(0.072±4.16)
1.02
(0.112±9.30)
0.228
(0.031±1.67)
0.599
(0.073±4.89)
Age (every year older) 1.07
(1.02±1.11)***
1.03
(0.974±1.09)
1.06
(1.00±1.12)*
1.03
(0.962±1.09)
1.06
(1.02±1.10)***
1.026
(0.977±1.078)
Incident wartsc 0.559
(0.191±1.64)
0.446
(0.124±1.60)
0.236
(0.031±1.80)
0.319
(0.040±2.55)
0.385
(0.135±1.101)*
0.288
(0.088±0.945)*
Smoking
Never smokers 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Ex-smokers 1.22
(0.495±3.00)
1.28
(0.44±0.71)
0.591
(0.172±2.02)
0.621
(0.149±2.59)
1.26
(0.576±2.75)
1.24
(0.489±3.16)
Curent smokers 0.740
(0.274±2.00)
0.721
(0.249±2.09)
1.21
(0.299±4.87)
1.48
(0.310±7.08)
0.714
(0.302±1.69)
0.705
(0.272±1.83)
aSCC, squamous-cell carcinomas; BCC, basal-cell carcinomas; NMSC, non-melanoma skin cancer; HTR, heart transplant recipient. bAdjusted for all other variables
shown in the table. The small number of women in the sample precluded to compute the relative risk of gender for BCC. cAfter heart transplant and previous to NMSC
development. *p<0.05, **p<0.01, ***p<0.001 in the likelihood ratio text (Cox proportional hazard regression).
Table II. Risk of developing NMSC along the follow-up period (120 mo) according to the joint exposure to TSB (previous to
transplant) and ST in HTRa
Skin type
Tans in sun (III/IV) Burns in sun (I/II)
Absolute risks: percentage developing NMSC (95% con®dence intervals)
Total sun burden score (see Table I) Low (<6) 0% (0.0±14.6) 18.2% (3.2±48.3)
Moderate (6±10) 13.7% (6.2±25.3) 53.3% (28.7±76.8)
High (>10) 29.4% (11.7±53.7) 100% (76.2±100.0)
Relative risks: hazard ratios for developing NMSC (95% con®dence intervals)
Total sun burden score (see Table I) Low (<6) 1 (ref.) 1.81 (0.375±8.72)
Moderate (6-10) 1 (ref.) 8.67 (3.11±24.17)
High (>10) 4.15 (1.31±13.21) 20.19 (7.71±72.84)
aNMSC, non-melanoma skin cancer; TSB, total sun burden; ST, skin type; HTR, heart transplant recipients
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developing any NMSC. Multivariable Cox models were used to
control for some potential confounders (gender, age, smoking,
incident warts).
At the end of follow-up (161 mo), 33 patients had developed
either SCC, BCC, or both. All patients with ST-I developed at
least one NMSC. This proportion was 53% for ST-II, 13% for
ST-III, and none for ST-IV (only four patients). The higher
the TSB was, the higher was the incidence of SCC and BCC
(Table I). The group with highest TSB previous to transplant
exhibited highly signi®cant adjusted relative risks for SCC
(19.86), BCC (6.08), and any of both (13.71) (Table I). The
relative risk reduction associated with having a ST III/IV were
87% (SCC), 62% (BCC), and 83%, for any of them (Table I).
This estimate was not signi®cant for BCC. Contrary to what
was expected, the development of warts after the heart
transplant was not predictive of a higher risk of SCC or
BCC, and even an inverse association was found for any of
them (p = 0.02). When we considered deaths as events the
results did not substantially change (data not shown).
The cumulative absolute risk of developing any NMSC by joint
categories of exposure to TSB and ST was shown to be highly
predictive (Table II). We also estimated the adjusted relative
hazards for each joint category of TSB and ST, but we used as the
reference the merging of two strata (total: 70 patients) with score
< 10 for TSB and ST III/IV. The relative risks were 4.15 for ST
III/IV and TSB > 10; 8.67 for ST I/II and TSB = 6±10, and 20.19
for ST I/II and TSB score > 10.
Our study, which included a follow-up longer than previously
published reports (Olivari et al, 1990; EspanÄa et al, 1995; Euvrard
et al, 1995; Jensen et al, 1999), identi®ed two major risk factors
explaining the high incidence of NMSC in HRT: ST and the total
amount of exposure to sunlight, previously to the transplant. In
addition, our data do not support the consideration of viral warts as
an early marker for tumor development among HTR.
In the general population of Spain (Zubiri et al, 1981), the ratio
SCC/BCC is 0.3/1. We found a slightly higher incidence of BCC
during the earlier period of follow-up, but progressively the ratio of
SCC/BCC was reversed, reaching 1.66/1 at the end of the study.
There are few published studies assessing the role of ST in
determining the risk of NMSC among HTR and among transplant
recipients in general (McLelland et al, 1988). Our main results lead
us to think that patients who are candidates for heart transplant and
have a ST I or II will experience extremely high rates of NMSC in
the long run. This risk must be taken into account for thoroughly
balancing it against the potential bene®ts of a heart transplant.
Our results also support the importance of TSB previously to
receiving the transplant. We provide strong evidence to recom-
mend that when patients with a high TSB receive a transplant, they
must undergo an especially stringent dermatologic surveillance for
skin cancer.
The system we have used to score TSB in HTR has been
shown to predict rates of developing NMSC in these patients.
When combined with the ST, it can be used as a practical
approach for classifying HRT according to their risk of
developing these malignancies. This information could help
improve the setting of priorities in selecting patients for heart
transplant; however, we acknowledge that an external prospec-
tive validation of this scoring system with a different series of
patients is needed.
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No Modulation of Circulating Natural Killer Cell and Natural
Killer Receptor Bearing Memory T Cell Subsets in Patients
with Atopic Dermatitis
To the Editor:
Atopic dermatitis (AD) is a chronic in¯ammatory skin disease with
abnormalities of both cell-mediated and humoral immunity, and
increased susceptibility to cutaneous infections. Natural killer cells
provide a ®rst line of defence against virus. The aim of our study
was to determine the characteristics of circulating natural killer
receptor bearing cells in patients with AD.
Two families of natural killer receptor molecules have been
identi®ed in humans. The ®rst are type I transmembrane proteins
belonging to the Ig superfamily, such as p58.1/CD158a, p58.2/
CD158b (Moretta et al, 1993), p70/CD158d (Litwin et al, 1994),
p140/CD158j (Pende et al, 1996), and BY 55/CD160
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